Rifampin-zotepine interaction reduces effectiveness of antipsychotic drugs in a stable schizophrenia patient.
Ming-Shang
MS
Pai
Szu-Nian
SN
Yang
I-Shin
IS
Shiah
D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D000995:Antitubercular Agents / Q000009:adverse effects* / Q000627:therapeutic use; D003988:Dibenzothiepins / Q000009:adverse effects* / Q000627:therapeutic use; D004347:Drug Interactions; D005260:Female; D006801:Humans; D008875:Middle Aged; D012293:Rifampin / Q000009:adverse effects* / Q000627:therapeutic use; D012559:Schizophrenia / Q000150:complications* / Q000188:drug therapy*; D012565:Schizophrenic Psychology; D014376:Tuberculosis / Q000150:complications* / Q000188:drug therapy*
D014150:Antipsychotic Agents; D000995:Antitubercular Agents; D003988:Dibenzothiepins; C022172:zotepine; D012293:Rifampin